Zymeworks Inc.
Status: Publicly traded
Direct answer
Zymeworks Inc. is publicly traded on NASDAQ under the ticker ZYME.
Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, advancing, and bringing to market biological therapies aimed at combating cancer. Its pipeline features two primary experimental treatments: zanidatamab, a cutting-edge bispecific antibody currently undergoing Phase 1 and Phase 2 studies for various malignancies such as those affecting the biliary tract,...
Can you invest in Zymeworks Inc.?
Yes. Zymeworks Inc. is publicly traded on NASDAQ under the ticker ZYME.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Zymeworks Inc.
Detailed equity research is provided by MarketSnap.